Influence of time elapsed between myocardial infarction and coronary artery bypass grafting surgery on operative mortality

Voisine, Pierre; Mathieu, Patrick; Doyle, Daniel; Perron, Jean; Baillot, Richard; Raymond, Gilles; Métras, Jacques; Dagenais, François
March 2006
European Journal of Cardio-Thoracic Surgery;Mar2006, Vol. 29 Issue 3, p319
Academic Journal
Abstract: Objective: Optimal timing for CABG surgery after myocardial infarction (MI) remains controversial. We examined the influence of patient age and time elapsed between MI and isolated CABG surgery on operative mortality. Methods: Perioperative data of 13,545 patients who underwent isolated CABG surgery from 1991 to 2005 were reviewed. A previous MI was found in 7219 patients, classified among groups A–E whether they underwent surgery less than 6h (A, n =26), between 6 and 24h (B, n =51), between 1 and 7 days (C, n =313), between 8 and 30 days (D, n =917), or more than 30 days (E, n =5912) after the event. Crude percentages and odds ratio estimates of operative mortality were calculated. Results: In patients who had no history of MI, the mortality rate was 1.7%, while it was, respectively, 19.2, 9.8, 8.6, 3.2, and 2.4% in patients from groups A to E. Among 6589 patients over 65 years of age, 3027 had no history of MI. Their mortality was 2.4%, compared to, respectively, 35.7, 13.8, 11.3, 5.1, and 3.9% for those belonging to groups A–E. Overall odds ratio estimates of operative mortality were 3.92 (p =0.19), 5.08 (p =0.002), 4.33 (p =0.0001), 1.50 (p =0.08), and 1.18 (p =0.24) for groups A–E, respectively. Conclusions: Operative mortality is not influenced by a history of MI sustained more than 30 days prior to isolated CABG surgery, but is highly and most significantly increased between 6h and 1 week after MI, especially in older patients. That critical period should be avoided whenever possible.


Related Articles

  • Take heart: Targeted intervention shows results. Condon, Deborah // World of Irish Nursing & Midwifery;Feb2006, Vol. 14 Issue 2, p26 

    The article focuses on the national heartwatch program which has aimed at reducing morbidity and mortality in Ireland. The country has hold the title of the highest coronary heart disease death rate within the European Union. This heartwatch program has been considered as one of the most...

  • Is impairment of ischaemic preconditioning by sulfonylurea drugs clinically important? Meier, J. J.; Gallwitz, B.; Schmidt, W. E.; Mügge, A.; Nauck, M. A. // Heart;Jan2004, Vol. 90 Issue 1, p9 

    In the UGDP study, published in the 1970s, a high incidence of cardiovascular mortality was found in patients treated with the sulfonylurea agent tolbutamide. Impaired ischaemic preconditioning is presumed to be the most important mechanism for the excess cardiovascular mortality observed....

  • Surgery as early revascularization after acute myocardial infarction. Yavuz, Şenol // Anatolian Journal of Cardiology / Anadolu Kardiyoloji Dergisi;Nov2008 Supplement, Vol. 8, p84 

    Acute myocardial infarction (AMI) is the leading cause of morbidity and mortality in most industrialized nations throughout the world. Options for myocardial revascularization include thrombolysis or percutaneous coronary intervention (PCI) in the early period after AMI, or coronary artery...

  • Bypass grafting outcomes the same on or off pump.  // Nursing Standard;4/14/2004, Vol. 18 Issue 31, p10 

    Discusses the findings of a research that compared the outcome of off-pump and on-pump coronary artery bypass grafting. Cardiac stabilization devices; Mortality; Transfusion rate; Incidence of myocardial infarction and stroke; Mean time to extubation; Length of inpatient stay.

  • Cluster analysis: a useful technique to identify elderly cardiac patients at risk for poor quality of life. Fukuoka, Yoshimi; Lindgren, Teri G.; Rankin, Sally H.; Cooper, Bruce A.; Carroll, Diane L. // Quality of Life Research;Dec2007, Vol. 16 Issue 10, p1655 

    Objective: The purposes of this study are (1) to examine the frequency of cardiac symptoms in elderly people one year after acute myocardial infarction (AMI) and/or coronary artery bypass surgery (CABG); (2) to identify patient subgroups (cluster solutions) based on cardiac symptoms...

  • Harnessing the preconditioning phenomenon: does remote organ ischaemia provide the answer? Burdess, A.; Newby, D. // Heart;Oct2006, Vol. 92 Issue 10, p1367 

    The article discusses various studies on the cellular mechanisms of the ischemic preconditioning phenomenon. C.E. Murry and colleagues described that pretreatment with brief periods of ischemia paradoxically resulted in a reduction in infarct size. The study by D. M. Yellon and colleagues...

  • Selection of patients for coronary angiography and coronary revascularization early after myocardial infarction: is there evidence for a gender bias? Krumholz, Harlan M.; Douglas, Pamela S.; Lauer, Michael S.; Pasternak, Richard C.; Krumholz, H M; Douglas, P S; Lauer, M S; Pasternak, R C // Annals of Internal Medicine;5/15/92, Vol. 116 Issue 10, p785 

    Objective: To determine whether a gender bias exists in the selection of patients for diagnostic and therapeutic cardiovascular procedures early after myocardial infarction. Design: A retrospective cohort study. Setting: A community-based tertiary care...

  • Role of troponin I, myoglobin, and creatine kinase for the detection of early graft failure following coronary artery bypass grafting. Thielmann, Matthias; Massoudy, Parwis; Marggraf, Günter; Knipp, Stephan; Schmermund, Axel; Piotrowski, Jarowit; Erbel, Raimund; Jakob, Heinz // European Journal of Cardio-Thoracic Surgery;Jul2004, Vol. 26 Issue 1, p102 

    Objective: The detection of early graft failure following coronary artery bypass grafting (CABG) enables immediate reintervention and may significantly limit myocardial damage, thus potentially improving outcome. To date, non-invasive indicators of early graft failure following coronary surgery...

  • Prognosis of No-reflow Phenomenon. Crawford, Michael H. // Clinical Cardiology Alert;Jul2010, Vol. 29 Issue 7, p53 

    LITTLE IS KNOWN ABOUT THE LONG-TERM PROGNOSIS OF THE no-reflow phenomenon after percutaneous intervention (PCI) for acute ST elevation myocardial infarction (STEMI). Thus, these investigators from Munich, Germany, studied 1,406 patients with STEMI presenting within 24 hours of symptom onset and...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics